Abbott | ABT - Assets


Abbott reported $110.43B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.07B 252M Mar/2026
AtriCure USD 676.64M 32.66M Jun/2026
Baxter International USD 19.79B 55M Jun/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
Danaher USD 92.37B 8.82B Jun/2026
Dexcom USD 6.46B 178M Jun/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Globus Medical USD 5.44B 136.79M Mar/2026
Insulet USD 2.99B 203.2M Mar/2026
Integra LifeSciences USD 3.56B 14.24M Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
J&J USD 201.06B 167M Jun/2026
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.86B 144.34M Jun/2026
Pfizer USD 201.13B 6.49B Jun/2026
Smith & Nephew USD 11.01B 321M Jun/2026
Solventum Corp USD 14.1B 197M Mar/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
Terumo JPY 2.31T 55.3B Mar/2026
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026